Literature DB >> 15611477

Structures of thymidine kinase 1 of human and mycoplasmic origin.

Martin Welin1, Urszula Kosinska, Nils-Egil Mikkelsen, Cecilia Carnrot, Chunying Zhu, Liya Wang, Staffan Eriksson, Birgitte Munch-Petersen, Hans Eklund.   

Abstract

Cytosolic thymidine kinase 1, TK1, is a well known cell-cycle-regulated enzyme of importance in nucleotide metabolism as well as an activator of antiviral and anticancer drugs such as 3'-azido-3'-deoxythymidine (AZT). We have now determined the structures of the TK1 family, the human and Ureaplasma urealyticum enzymes, in complex with the feedback inhibitor dTTP. The TK1s have a tetrameric structure in which each subunit contains an alpha/beta-domain that is similar to ATPase domains of members of the RecA structural family and a domain containing a structural zinc. The zinc ion connects beta-structures at the root of a beta-ribbon that forms a stem that widens to a lasso-type loop. The thymidine of dTTP is hydrogen-bonded to main-chain atoms predominantly coming from the lasso loop. This binding is in contrast to other deoxyribonucleoside kinases where specific interactions occur with side chains. The TK1 structure differs fundamentally from the structures of the other deoxyribonucleoside kinases, indicating a different evolutionary origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611477      PMCID: PMC539776          DOI: 10.1073/pnas.0406332102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Structure and function of cellular deoxyribonucleoside kinases.

Authors:  S Eriksson; B Munch-Petersen; K Johansson; H Eklund
Journal:  Cell Mol Life Sci       Date:  2002-08       Impact factor: 9.261

2.  Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA.

Authors:  B F Luisi; W X Xu; Z Otwinowski; L P Freedman; K R Yamamoto; P B Sigler
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

Review 3.  Ureaplasma urealyticum.

Authors:  M M Hudson; M D Talbot
Journal:  Int J STD AIDS       Date:  1997-09       Impact factor: 1.359

4.  Crystal structure of varicella zoster virus thymidine kinase.

Authors:  Louise E Bird; Jingshan Ren; Alan Wright; Kris D Leslie; Bart Degrève; Jan Balzarini; David K Stammers
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

5.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

Authors:  Robert L Strausberg; Elise A Feingold; Lynette H Grouse; Jeffery G Derge; Richard D Klausner; Francis S Collins; Lukas Wagner; Carolyn M Shenmen; Gregory D Schuler; Stephen F Altschul; Barry Zeeberg; Kenneth H Buetow; Carl F Schaefer; Narayan K Bhat; Ralph F Hopkins; Heather Jordan; Troy Moore; Steve I Max; Jun Wang; Florence Hsieh; Luda Diatchenko; Kate Marusina; Andrew A Farmer; Gerald M Rubin; Ling Hong; Mark Stapleton; M Bento Soares; Maria F Bonaldo; Tom L Casavant; Todd E Scheetz; Michael J Brownstein; Ted B Usdin; Shiraki Toshiyuki; Piero Carninci; Christa Prange; Sam S Raha; Naomi A Loquellano; Garrick J Peters; Rick D Abramson; Sara J Mullahy; Stephanie A Bosak; Paul J McEwan; Kevin J McKernan; Joel A Malek; Preethi H Gunaratne; Stephen Richards; Kim C Worley; Sarah Hale; Angela M Garcia; Laura J Gay; Stephen W Hulyk; Debbie K Villalon; Donna M Muzny; Erica J Sodergren; Xiuhua Lu; Richard A Gibbs; Jessica Fahey; Erin Helton; Mark Ketteman; Anuradha Madan; Stephanie Rodrigues; Amy Sanchez; Michelle Whiting; Anup Madan; Alice C Young; Yuriy Shevchenko; Gerard G Bouffard; Robert W Blakesley; Jeffrey W Touchman; Eric D Green; Mark C Dickson; Alex C Rodriguez; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Yaron S N Butterfield; Martin I Krzywinski; Ursula Skalska; Duane E Smailus; Angelique Schnerch; Jacqueline E Schein; Steven J M Jones; Marco A Marra
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

6.  Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice.

Authors:  Patrick Warren; Wendy Song; Eric Holle; Lilia Holmes; Yangzhang Wei; Jin Li; Thomas Wagner; Xianzhong Yu
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

7.  Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir.

Authors:  D G Brown; R Visse; G Sandhu; A Davies; P J Rizkallah; C Melitz; W C Summers; M R Sanderson
Journal:  Nat Struct Biol       Date:  1995-10

8.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

9.  Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway.

Authors:  Po-Yuan Ke; Zee-Fen Chang
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 10.  Ribonucleotide reductases.

Authors:  A Jordan; P Reichard
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  41 in total

1.  3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.

Authors:  Jay Lin; Vincent Roy; Liya Wang; Li You; Luigi A Agrofoglio; Dominique Deville-Bonne; Tamara R McBrayer; Steven J Coats; Raymond F Schinazi; Staffan Eriksson
Journal:  Bioorg Med Chem       Date:  2010-03-15       Impact factor: 3.641

2.  Computational molecular biology approaches to ligand-target interactions.

Authors:  Paola Lupieri; Chuong Ha Hung Nguyen; Zhaleh Ghaemi Bafghi; Alejandro Giorgetti; Paolo Carloni
Journal:  HFSP J       Date:  2009-03-10

3.  Exploiting temperature-dependent substrate promiscuity for nucleoside analogue activation by thymidine kinase from Thermotoga maritima.

Authors:  Stefan Lutz; Joseph Lichter; Lingfeng Liu
Journal:  J Am Chem Soc       Date:  2007-06-26       Impact factor: 15.419

4.  Quaternary structure change as a mechanism for the regulation of thymidine kinase 1-like enzymes.

Authors:  Dario Segura-Peña; Joseph Lichter; Manuela Trani; Manfred Konrad; Arnon Lavie; Stefan Lutz
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

5.  Trypanosoma brucei thymidine kinase is tandem protein consisting of two homologous parts, which together enable efficient substrate binding.

Authors:  Farahnaz Ranjbarian; Munender Vodnala; Sharvani Munender Vodnala; Reza Rofougaran; Lars Thelander; Anders Hofer
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

6.  Serum thymidine kinase 1 is a reliable maker for the assessment of the risk of developing malignancy: A case report.

Authors:  Zhiheng Chen; Hong Guan; Hong Yuan; Xia Cao; Yingxin Liu; J I Zhou; Ellen He; Sven Skog
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

Review 7.  N3-substituted thymidine bioconjugates for cancer therapy and imaging.

Authors:  Ahmed Khalil; Keisuke Ishita; Tehane Ali; Werner Tjarks
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

8.  2-(1,3-Dioxoisoindolin-2-yl)ethyl 4-methyl-benzene-sulfonate.

Authors:  Mark Daniel Bartholomä; Wayne Ouellette; Jon Zubieta
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-20

9.  Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.

Authors:  Hitesh K Agarwal; Craig A McElroy; Elena Sjuvarsson; Staffan Eriksson; Michael V Darby; Werner Tjarks
Journal:  Eur J Med Chem       Date:  2012-12-05       Impact factor: 6.514

10.  Directed evolution of an orthogonal nucleoside analog kinase via fluorescence-activated cell sorting.

Authors:  Lingfeng Liu; Yongfeng Li; Dennis Liotta; Stefan Lutz
Journal:  Nucleic Acids Res       Date:  2009-05-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.